Addressing the New Imperative to Include Females in Clinical Trials:

 

Take the guesswork out of meeting your goals for recruitment of women with this new Health Decisions white paper. Addressing the New Imperative to Include Females in Clinical Trials explains how sponsors can efficiently enroll women in studies across the therapeutic spectrum and comply with new NIH and FDA polices. Drawing on experience in more than 300 trials, the white paper:

Drawing on experience in > 300 trials, the white paper from leading reproductive and women's health CRO Health Decisions. 

Download this white paper for tips addressing the new imperative to include females in clinical trials. 

numerals only please